Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1,705,327.0 | $7.1M | 0.67% | -350K | -17.0% | $4.16 | +163.1% |
| 22 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 16,325.0 | $6.1M | 0.57% | -350.0 | -2.1% | $371.67 | -7.6% |
| 23 | CAH | CARDINAL HEALTH INC | Healthcare | 22,500.0 | $5.3M | 0.51% | -4K | -16.7% | $237.56 | -7.3% |
| 24 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 17,200.0 | $5.2M | 0.49% | -17K | -50.1% | $301.03 | -16.1% |
| 25 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 128,000.0 | $5.0M | 0.47% | -32K | -20.0% | $39.01 | -8.9% |
| 26 | IONS | IONIS PHARMACEUTICALS INC | Healthcare | 59,900.0 | $4.7M | 0.45% | -33K | -35.5% | $79.29 | -43.5% |
| 27 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 179,000.0 | $4.6M | 0.43% | -20K | -10.1% | $25.72 | -21.8% |
| 28 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 8,050.0 | $4.3M | 0.41% | -16K | -66.5% | $536.95 | -4.5% |
| 29 | AMGN | AMGEN INC | Healthcare | 11,900.0 | $4.3M | 0.41% | -3K | -21.7% | $362.12 | +13.0% |
| 30 | WAY | WAYSTAR HLDG CORP | Technology | 178,566.0 | $3.7M | 0.35% | -164K | -47.9% | $20.53 | +19.8% |
| 31 | VEEV | VEEVA SYS INC | Healthcare | 17,300.0 | $3.1M | 0.29% | -68K | -79.7% | $177.47 | +57.4% |
| 32 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 225,000.0 | $2.2M | 0.21% | -80K | -26.2% | $9.82 | -1.9% |
| 33 | STOK | STOKE THERAPEUTICS INC | Healthcare | 64,500.0 | $2.1M | 0.20% | -18K | -22.3% | $32.72 | -23.1% |
| 34 | DOCS | DOXIMITY INC | Healthcare | 76,107.0 | $1.6M | 0.15% | -108K | -58.6% | $20.74 | +27.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%